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Until  recently, we knew of no biochemical basis  for the cytotoxic activity of any 
mononuclear leukocyte (macrophage or lymphocyte). Thymidine (1) and arginase (2, 
3) are now thought to account for some of the in vitro cytostatic and cytolytic effects 
of macrophages. However, those molecules seem unlikely to mediate similar effects of 
macrophages in vivo, except perhaps in areas of minimal perfusion. More is known 
about the cytotoxic molecules released by granulocytes. When exposed to phagocytic 
particles (4-6) or lectins (7), granulocytes release hydrogen peroxide. Acting together 
with myeloperoxidase and a  halide  (8),  granulocyte-derived hydrogen peroxide can 
participate  in  the  destruction  of eukaryotic  cells  in  vitro  (8,  9).  Enzymatically 
generated hydrogen peroxide has been known for some time to lyse mammalian cells 
in the presence of a peroxidase and halide (10-12). 
Mouse peritoneal macrophages can release hydrogen peroxide almost as copiously 
as  granulocytes,  provided  the  cells  are  both  activated  and  triggered  in  vitro  (13). 
Similar conditions lead to the release of comparable quantities of superoxide anion 
(14).  These  findings  led  us  to  investigate  the  extracellular  cytotoxic potential  of 
macrophages  after sequential  activation  and  triggering.  Suitably  activated  macro- 
phages, as well as granulocytes, proved to be cytotoxic after exposure to a  soluble, 
membrane-active  agent,  phorbol  myristate  acetate  (PMA). 1 Study of a  variety of 
effector and  target  cells  provided  correlative  evidence  consistent  with  a  role  for 
hydrogen peroxide as  the  effector molecule. The rapidity and  potency of cytolysis 
made this model suitable  for analysis at  the biochemical level, as described in  the 
accompanying report (15). 
Materials and Methods 
Mice.  Female  (BALB/c  x  DBA/2)Ft  (CDFx)  (H-2  a/a) (Flow  Laboratories,  Dublin,  Va.) 
and NCS  mice  (outbred)  (Rockefeller University), aged 6-20 wk,  were used,  with equivalent 
results. 
* Supported by grant CA-22090 from the National Cancer Institute. 
:~ Scholar of the Leukemia Society of America. 
Abbreviations used in this paper: BCG, Bacille Calmette-Gu~rin; DMSO, dimethyl sulfoxide; E:T, effector 
cell  to target cell ratio; FBS,  heat-inactivated (56°C, 30 min) fetal bovine serum; KRPG,  Krebs-Ringer 
phosphate  buffer with  5.5  mM  glucose;  LPS,  bacterial  lipopolysaccharide;  MEM,  Eagle's  minimum 
essential medium with Earle's salts,  penicillin and streptomycin; MEM-S, MEM with  1% FBS;  NPAC, 
nonphagocytic adherent cells; PMA, phorbol myristate acetate. 
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Injectibles.  Bacille Calmette-Gu6rin  (BCG),  C. parvum,  casein, and  thioglycollate were ob- 
tained and administered i.p. as described (13). The BCG was of the Pasteur type (TMC 1011). 
Peritoneal cells were harvested 10 d-6 wk after the injection of 10  7 viable bacilli. Macrophages 
elicited with a 4% thioglycollate broth obtained from Dr. Richard Johnston (National Jewish 
Hospital, Denver, Colo.) gave results equivalent to cells elicited with the 10% preparation used 
in the majority of experiments. Granulocytes were harvested  10-20 h  and  macrophages 4 d 
after injection of thioglycollate broth. 1 ml of 1% proteose-peptone (Difco Laboratories, Detroit, 
Mich.) was given i.p. 4 d before cell collection. 
Preparation  of Peritoneal  Cells.  Peritoneal cells were collected, subjected to hypotonic lysis of 
erythrocytes, washed, counted, stained, and scored as described (13).  Nonadherent and non- 
phagocytic adherent  cells were prepared from  BCG-treated mice as before (16).  To remove 
nonadherent cells, peritoneal cells were added to 12  ×  75 mm glass test tubes, centrifuged at 
180 g for 5 min, and allowed to adhere at 37°C for 1 h in Eagle's minimum essential medium 
with Earle's salts (MEM)  (Grand Island Biological Co., Grand Island, N. Y.)  containing 1% 
heat-inactivated fetal bovine serum (FBS) (Flow Laboratories, Inc., Rockville, Md.), 100 U/ml 
penicillin, and  100/~g/ml streptomycin (MEM-S). The tubes were drained and rinsed three 
times with  Krebs-Ringer phosphate buffer with  5.5  mM  glucose  (KRPG)  (13).  To  deplete 
granulocytes, 2  ×  107 peritoneal cells in 2 ml of MEM-S were layered over 3 ml of FicoU- 
Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N.J.) in a  15-cubic 
centimeter conical tube  (Corning Glass Works, Science Products Div., Corning,  N. Y.)  and 
centrifuged at 300 g for 10 min in the cold. The upper cell layer was removed and washed. 
Other Cells.  For mouse erythrocytes, blood was collected from the axillary vessels, antico- 
agulated with 50 U/ml heparin, and washed twice in KRPG, discarding the buffy coat. For 
spleen cells, CDF1 spleens were teased with forceps, the clumps discarded after settling, and the 
remaining cells subjected to hypotonic lysis (13) and washed twice in MEM. Spinner cultures 
of the macrophage lines J774  (H-2  a) and P388D1  (H-2a), and the L-cell fibroblast line, were 
the gift of Dr. Jay Unkeless (Rockefeller University). A monolayer of nontransformed, diploid 
human foreskin fibroblasts (FS4) was the gift of Dr. P. Sehgal (Rockefeller University). Tumors 
were maintained by serial passage of ascites: P388 (H-2a), P815 (H-2  a) (from Dr. Unkeless) and 
SL2  (H-2  a)  (17)  in  CDF:  mice,  and  TLX9  (H-26)  (17)  in  C57BL/6  mice  (The  Jackson 
Laboratories, Bar Harbor, Maine). 
Hydrogen peroxide  release.  The previously described assay (13) was modified by the use of 5 
nmol  of scopoletin and  30 #g  of horseradish peroxidase in  3  ml  of KRPG.  The  assay was 
performed in an MPF-44 fluorometer (Perkin-Elmer Corp., Instrument Div., Norwalk, Conn.). 
Agents tested for their ability to trigger hydrogen peroxide release were: PMA (Consolidated 
Midland Corp., Brewster, N. Y.), digitonin (Sigma Chemical Co., St. Louis, Mo.), the ionophore 
A23187 (the gift of Dr. Robert Hamill, Eli Lilly Co., Indianapolis, Ind.), NaF (Fisher Scientific 
Co., Pittsburgh, Pa.), and the following preparations of bacterial lipopolysaccharide (LPS), all 
from Sigma Chemical Co.: butanol, phenol, and trichloroacetic acid extracts of Escherichia  coli 
0127:B8, phenol extract of E. coli 026:B6, and phenol extract of Salmonella  typhosa. 
Cytotoxicity Assay.  Target cells, usually numbering 3 ×  107, were suspended in 2 ml of MEM 
with  100-200/xCi of Na2B1CrO4 (1  mCi/ml in saline, New England Nuclear, Boston, Mass.), 
incubated at 37°C in 7% CO2 in air for 45  min, and washed four times by centrifugation in 
MEM-S.  Cell concentration  was  determined  by hemocytometer counting and  viability by 
trypan blue exclusion. The desired number of target cells (usually 2  X  104-6  ×  104)  in  1 ml of 
MEM-S was dispensed to  12  X  75 mm borosilicate glass culture tubes (Fisher Scientific Co.) 
in  an  ice bath. The  tubes already contained 0.02  ml of KRPG  in which was dissolved the 
pharmacologic agent to be tested. Unless otherwise stated, the latter was PMA (maintained as 
a  stock solution of 0.3  mg/ml  in dimethylsulfoxide at  -70°C).  Control  tubes contained an 
equal volume of dimethyl sulfoxide (DMSO) (Sigma Chemical Co.) in KRPG. The activity of 
PMA in KRPG was lost if it was passed through a Millipore filter (Millipore Corp., Bedford, 
Mass.). Next,  1 ml of MEM-S containing various numbers of effector cells (usually 2  ×  105-1 
×  106) was added, giving a final concentration of PMA of 10 ng/ml (16.7 nM) and of DMSO 
of 0.0033%  (vol/vol). The tubes were transferred to precooled carriers and centrifuged at  180 
g for 5 min (TJ6R, Beckman Instruments, Inc., Fullerton, Calif.). The carriers were placed in 
a  37°C water bath for 60 s, then transferred to a humidified incubator (7% CO2)  at 37°C for 
4.5 h. They were then centrifuged at 700 g for  10 min, and the upper  1 ml transferred to a 86  I. CYTOLYSIS  BY  MACROPHAGES AND GRANULOCYTES 
second tube (sample tube). The original tube was designated the residual tube. Both tubes were 
counted  in a  gamma spectrometer (Packard Instrument Co.,  Inc., Downers Grove, Ill.). To 
measure the cytotoxicity of reagent hydrogen peroxide, dilutions of Superoxol (J. T.  Baker 
Chemical Co., Phillipsburg, N. J.) in 0.02 ml KRPG were added to the tubes instead of PMA, 
and effector cells were omitted. Assays were done in triplicate. 
Computations.  Percent release (R) of ~lCr was taken to be: 
R  =  2.02  (sample -  Bgd)  ×  100, 
sample +  residual -  2Bgd 
where Bgd indicated machine background of the gamma spectrometer, and 2.02  =  total assay 
volume/volume of sample. Specific release (SR) was taken as: 
SR  =  l~,~a~enua-l~spont, x  100, 
where l~r~z, represented the mean percent of 51Cr released from an aliquot of target cells diluted 
fivefold in distilled water and frozen four times in an acetone-dry ice bath, and Rspont. was the 
mean  percent  of 51Cr released by target cells cultured without  effector cells. The  SEM  for 
triplicate R  values was adjusted by dividing it by the factor,  (1~,,~  -  l~spont.)/100.  Partway 
through these studies, the availability of a  computer made it practical to estimate the SEM 
more accurately as: 
SEM  =  [{n,~v. [(15,,~.  -  15--~pont.)SEM~w.]  2 +  n,pont.[(15,,~,.-  15,,,p.)SEM~nt]  2 
+  n  ....  [(l~,xp. -- Rspo,t)SEMmax]2}/nezp.  .  .(l~max. -- l~.,pont4~411/2.1 X  t00. 
For 100 consecutive triplicates, the SEM as calculated above averaged 2.16%  release of 51Cr, 
whereas the simple proportional SEM for the same triplicates averaged 2.04%. For consistency, 
when  data  are  presented  below for  individual triplicates, the  simple proportional SEM  is 
reported. 
Effector  cell  to  target  cell  (E:T)  ratios were  calculated on  the  basis  of the  number  of 
macrophages  and  monocytes  added,  except  for  cells harvested  10-20  h  after  injection of 
thioglycollate broth,  in  which  case  the  ratio  was  based  on  the  number  of granulocytes 
(neutrophils plus eosinophils). The  number  of cells of each  type was calculated from  their 
percentage on the differential count and the total number of peritoneal cells added. 
Scanning Electron Microscopy.  As performed by Dr. Gilla Kaplan, cultures in 1 ml of MEM-S 
on glass coverslips were fixed by the addition of an equal volume of 5% glutaraldehyde in 0.1 
M sodium cacodylate, pH 7.4, dehydrated through graded alcohols, transferred to amyl acetate, 
subjected to critical point drying in liquid CO2  in a  Sorval CPD system, coated with  gold 
(Edwards  5150  sputter  coater  (Edwards  High  Vacuum,  Inc.,  Grand  Island,  N.Y.)),  and 
examined in an ETEC Autoscan (ETEC, Inc., Hayward, Calif.) 
Results 
Extracellular  Lysis  of P388  Lymphoma Cells by  BCG-Induced  Peritoneal Cells and  by 
Granulocytes in the Presence of PMA.  Table I summarizes the results of all 9 ! experiments 
conducted in the standard manner using the lymphoma P388 as a  target. Peritoneal 
cells taken from BCG-treated mice (BCG cells) and granulocyte-rich peritoneal cells 
taken  from  mice  10-20  h  after injection of thioglycollate broth, readily lysed P388, 
but only when triggered by PMA. Peritoneal cells from untreated mice, or from mice 
given thioglycollate broth  4  d  previously, were ineffective. The compositions of the 
effector cell populations are shown in Table II. 
The validity of the assay was investigated further. BCG-induced macrophages were 
cultured with  P388  cells with or without  PMA  and examined by scanning electron 
microscopy, kindly performed by Dr. Gilla Kaplan. In two experiments, there were 
76 and 91%  reductions, respectively, in the total number of visible P388  cells in the NATHAN, BRUKNER,  SILVERSTEIN, AND COHN 
TABLE  I 
Lysis ofP388 Lymphoma Cells by Peritoneal Cells Triggered with PMA 
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Treatment of mice  No. exp. 
E:T ratio* 
mean ±  SEM 
(range) 
Percent specific release of 51Cr:~ 
mean ±  SEM (range) 
DMSO  PMAII 
vehicle§ 
BCG 
Thioglycollate, 10-20 h 
(granulocytes)¶ 
None 
ThioglycoUate,  4 d** 
38  t9 ±  1.2  1.5 ±  1.0  78.1 ±  2.l 
(7-30)  (39.6-104) 
20  13 ±  2.1  1,0 ±  0,7  87.3 ±  3.4 
(3-33)  (50.5-113) 
26  18 +  1.3  -6,2 +  1.9  -4.4 ±  1.6 
(7-27)  (-18.1-11.4) 
7  36 ±  3.9  -8.2 ±  6.0  -0.4 ±  2.6 
(22-45)  (-15-4.9) 
* Effector to target ratio, calculated from the number of peritoneal cells added and the percentage of 
effector cells on the differential count (see Materials and Methods). 
:t: The viability of P388 immediately before adding effector cells averaged 96.1 +  0.4%. The 51Cr release 
after 4 cycles of freezing and thawing averaged 85.0 ±  0.7%. The spontaneous release without PMA 
averaged 14.7 ±  0.9%, and the spontaneous release with PMA averaged 15.6 ±  0.9% (48 preparations 
of tumor cells). Assay time, 4.5 h, with 2 ×  104-8 ×  104 P388 cells per tube. 
§ DMSO, 0.0033% (vol/vol). 
}1PMA, 10 ng/ml (16.7 nM). 
¶ Cells harvested 10-20 h after i.p. injection of thioglycollate broth. 
** Cells harvested 4 days after i.p. injection of thioglycollate broth. 
TABLE II 
Characterization of Peritoneal Cell Suspensions 
Treatment of mice 
No. cells per 
No.  mouse  ×  10  -n 
exp.  mean  ±  SEM  Macrophages 
+  monocytes 
Percent of peritoneal cells, mean  ±  SEM 
Lymphocytes  Mast cells  Eosinophils  Neut  rophils 
BCG  53  5.7  ±  0.3  40.9 +  1.2  52.0 ±  1,2  0.I4  +  0.04  0.13 ±  0.03  6.8  ±  0.3 
Thioglycollate, 10-20 h  23  13.7  ±  0.8  25.9 ±  1.2  8.2 ±  1.5  0.06 :t: 0.04  2.9  ±  0.60  63.0  ±  2.1 
None  45  4.7 ±  0.2  45.1  ±  1,5  53.3  "*-  1.6  0.57 ±  0.12  0.32 ±  0.06  0.67  ±  0,10 
Thioglyeollate, 4 d  8  26.0 ±  4.1  78.5  ±  3.8  10.4  ±  2.5  0.23  ±  0.10  B.0  "4-  1.6  3.3  ±  1.3 
cultures containing BCG-induced macrophages and PMA, with 89 and 96% reduc- 
tions in the number of P388 cells which appeared viable by morphologic criteria. The 
cytotoxicity  assay  was  performed  at  a  somewhat  lower  effector  cell  density,  and 
resulted in 71 and 76% specific release of 51Cr in the same experiments. 
The  BCG-induced macrophages  were  well  spread,  but  PMA  induced  an  even 
greater  degree  of spreading.  As seen in Fig.  1,  the  zone of macrophage-tumor cell 
contact  was  disk-like, without  extensive areas  of membrane apposition.  Lysis was 
extracellular (Fig.  1 c, d), and no phagocytosis of tumor cells was observed. Lympho- 
cytes adjacent to dead tumor cells appeared undamaged (Fig.  1 d). 
Release of 5XCr also correlated closely with reduction in the number oftrypan blue- 
excluding tumor cells.  For  these  experiments, adherent  granulocytes were  used  as 
effector cells, to minimize the possibility that any effector cells would be mistaken for 
target  cells  in  the  hemocytometer.  A  mean  specific  release  of  5XCr of  87%  was 
associated with a  mean reduction in trypan blue-excluding lymphoma cells of 89%. 
The cytotoxicity assay was not affected by retention of 5aCr  by adherent effector 
cells.  All  the  5XCr added  could be  recovered  after  rinsing the  reaction tubes with 88  I. CYTOLYSIS  BY  MACROPHAGES AND  GRANULOCYTES 
FIG.  1.  Scanning electron micrographs of peritoneal ceils from BCG-treated mice cultured for 4.5 
h with P388 lymphoma cells. Cultures in (a) and (b) received DMSO vehicle (0.0033%). Those in 
(c) and (d) received PMA (10 ng/ml). Magnifications: (a)  ×  3,280, (b)  ×  1,804, (c)  ×  1,640, (d) 
×  1,488. 
additional medium. Cytotoxicity was only slightly affected by varying the concentra- 
tion of FBS over a  wide range. For example, BCG-induced cells incubated with 51Cr- 
labeled P388 cells at an E:T ratio of 18  in the presence of PMA caused  79% specific 
release of SlCr at 0.1% FBS, 83% at  1.0% FBS (the standard amount), and 91% at 5% 
FBS. Results were similar when tumor cells were allowed to settle at unit gravity onto 
monolayers  of BCG-induced  macrophages  on  coverslips, compared  to  centrifuging 
target  cells  and  effector  cells  together  in  round-bottomed  tubes  in  the  standard 
manner  (data not shown). 
In  the  absence of effector cells, PMA  had  no  deleterious effect  on  P388  cells, as 
judged by scanning electron microscopy. Likewise, no toxicity of PMA for P388 cells 
was discernible by trypan blue exclusion, 51Cr release (Table I), or the survival time 
of mice injected i.p. with the P388 cells remaining after 4.5 h  of culture with DMSO I00 
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Fro. 2.  Time-course of 5tCr release from P388 lymphoma cells;  ×  ×, with  BCG-induced 
peritoneal cells and PMA (10 ng/ml),  not centrifuged. The remaining groups were centrifuged at 
the start of the assay: O  O, with BCG-induced peritoneal cells and PMA: O-----©, with BCG- 
induced  peritoneal  cells and DMSO vehicle; H,  with  normal peritoneal cells and PMA; 
0----0, with  normal  peritoneal  cells and  DMSO  vehicle. E:T ratio,  9.  Means  and  SEM  for 
triplicates. 
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(12.3  +  0.4 d) or PMA (12.6  +  0.5 d)  (initial cell number, 6  X  10  4, with six mice per 
group). 
Time-Course.  The above experiments were terminated  at 4.5 h. To learn how fast 
lysis occurred, and whether the superiority of BCG-induced cells over normal cells, as 
well  as  their  requirement  for  PMA,  was  still  evident  at  later  times,  samples  were 
harvested at intervals from 1 to 18.5 h. As shown in Fig. 2, little lysis was evident until 
:3 h. Thereafter, 51Cr was rapidly released from P388 cells in the presence of BCG cells 
and PMA, with only a slight increment between 4.5 and  18.5 h. Even at  18.5 h, BCG 
cells cultured without  PMA failed to induce lysis. Cytolysis by BCG-induced perito- 
neal cells was augmented if the tubes were centrifuged at  the start of the assay (Fig. 
2).  Normal  peritoneal  cells,  cultured  with  PMA,  were  minimally  cytotoxic only at 
18.5 h. 
We  next  investigated  whether  the  period  of injury  to  the  tumor  cells  might  be 
shorter than the time required for them to release SlCr. BCG-induced peritoneal cells 
were allowed to adhere in test tubes, and nonadherent cells were removed. The tumor 
cells were added and centrifuged.  At intervals,  the pellets were disrupted,  and one- 
half the medium transferred  to a  second tube. Thus, the second tube contained one- 
half the target cells, but few or no effector cells. All tubes were harvested at 4.5 h. As 
shown in Fig. 3, those target cells which were removed from adherent effector cells at 
0  time or at  30 min exhibited  no or only partial  51Cr  release  at  4.5  h.  However,  if 
P388 cells were removed from the adherent  BCG cells after  1 h  or more, they were 
fully lysed when tested at 4.5 h. It appeared that BCG cells inflicted an injury during 
the  1st h, which resulted in near-maximal  release of 51Cr at 4.5 h. 
Influence of Effector Cell Number.  To  compare  the  efficacy of eight  different  cell 
populations, effector cells were added to cultures of P388 cells at a variety of doses. As 
shown  in  Fig.  4,  peritoneal  cells  from mice which  had  received  BCG,  C. parvum, or 
short-term  thioglycollate  treatment  (granulocytes)  were  extremely  effective,  with 
similar dose-response curves, showing maximal or near maximal lysis at E:T ratios of 90  I.  CYTOLYSIS BY  MACROPHAGES AND GRANULOCYTES 
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25, 50% lysis at E:T ratios from  1.4 to 4.5,  and  detectable  lysis at ratios as low as 0.5. 
When  PMA  was omitted, however, no cytotoxicity resulted with these cells even at E: 
T  ratios as high  as  77  (Fig. 4a,  b).  In contrast,  normal  peritoneal  cells, cells taken  4 
d  after thioglycollate or proteose-peptose,  and J774 cells (a transformed,  macrophage- 
like line [18])  failed to lyse P388 cells at any dose tested, up to E:T ratios of 100  (Fig. 
4 c, d).  Casein-induced  peritoneal cells had  an intermediate efficacy (Fig. 4 b). 
The  relative potency of the cell populations  tested above correlated precisely with 
their ability to release hydrogen  peroxide in response  to  PMA.  The  ability of BCG-, 
C. parvum-,  and casein-induced cells, as well as granulocyte-rich populations,  to release NATHAN,  BRUKNER,  SILVERSTEIN,  AND  COHN  91 
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assay, the E:T ratio was 23. Spontaneous release of 51Cr ranged from 8.1%  +  0.4 to 9.7%  ±  0.1 for 
the different doses of PMA. Means and SEM of triplicates. 
detectable  H202,  and  the  relative  inability of thioglycollate-induced macrophages 
and normal peritoneal cells to do so, after exposure to PMA,  were reported earlier 
(13).  We  found  that  proteose-peptone induced  macrophages  released  <0.10  nmol 
H202/106 macrophages/5 rain after PMA (four experiments), and H202 release from 
J774 cells with or without PMA was undetectable (two experiments). 
Effect of PMA Dose.  To pursue further the correlation between lysis of P388 and 
secretion of H202, the effect of PMA dose on both processes was determined, using 
BCG-induced peritoneal cells.  The dose-response curves were almost identical, show- 
ing a  nearly optimal effect at  10 ng/ml  (16.7  nM)  (Fig. 5). As much as  100 ng/ml 
PMA failed to trigger H202 release or cytotoxic activity using peritoneal cells from 
untreated mice (not shown). 
Nature of the Effector Cell from BCG-Treated Mice.  The adherent cells in the BCG- 
induced peritoneal cell population displayed full lytic activity toward P388, whereas 
the nonadherent cells were inactive. One of three such experiments is shown in Table 
III.  Nonphagocytic  adherent  cells,  isolated  from  the  adherent  population,  were 
inactive as  well  (Table III).  This strongly implied  that  the  effector cell was  both 
adherent  and  phagocytic.  These  findings  correlated  with  the  ability  of the  same 
populations to release H202 in response to PMA (13). 
The remaining possibility, that  granulocytes could account for all of the activity 
seen  with  adherent  peritoneal cells  from  BCG-treated mice,  seemed remote,  after 
considering the data in Table II and Figs.  1 and 4. From these, it seemed that BCG- 
induced peritoneal cells, especially when tested at lower E:T ratios, contained too few 
granulocytes  to  account  for  anything  but  a  small  percentage  of their  activity. 
Moreover,  when  BCG-  or  C.  parvum-induced  peritoneal  cells  were  centrifuged  on 
Ficoll-Hypaque, their content of granulocytes could be reduced markedly, yet cyto- 
toxic activity was reduced only slightly (Table IV). 
When  granulocytes  were  added  back  in  different  numbers  to  Ficoll-Hypaque- 
passaged BCG cells, the resulting 51Cr release from P388 cells was equal to the sum of 92  I.  CYTOLYSIS  BY  MACROPHAGES  AND  GRANULOCYTES 
TABLE III 
Cytotoxicity of Subpopulations of BCG-Induced Peritoneal Cells 
Peritoneal ceils  No. added 
Percent specific release of 6~Cr* 
DMSO vehicle~:  PMA§ 
Unseparated  1 x  106  -14.8  +  2.6  81.9  +  5.1 
Adherent  From 1 X  10511  -17.2  +  3.0  89.7  +  6.4 
Nonadherent  2 x  10  G  -11.2  +  4.1  7.6 +  2.4 
I  x  106  -13.1  +  0.9  5.3  +  2.5 
4  x  106  -11.7  :t: 0.8  1.4 +  1.5 
NPAC¶  9.3  x  105  -13.9  :t:  2.0  -3.3  +  5.5 
8 X  104  --3.0  +  1.3  --2.7  +  1.7 
* From 2  ×  104 SlCr-labeled P388 cells. Means +  SEM of triplicates. 
* DMSO, 0.0033%  (vol/vol). 
§ PMA, 10 ng/ml. 
II 1 X  105 peritoneal cells were added to the tubes, allowed to adhere for 1 h, and nonadherent cells rinsed 
out (see Materials and Methods). 
¶ Nonphagocytic adherent cells, isolated as described (16). NPAC were 94.5% viable, with 0.84% contam- 
ination by phagocytic cells.  1 x  105 unseparated peritoneal cells were estimated to contain 8.6  ×  104 
NPAC, based on finding 41% macrophages-monocytes in the differential count, and 21% nonphagocytic 
cells by observation of well-washed, postphagocytic adherent cell monolayers. 
TABLE IV 
Effect of Reduction of Granulocyte Content on Cytotoxic Activity of Peritoneal Cells 
Percent 
Experi-  Treatment of mice  Peritoneal cells  Number added  granulo-  Percent specific re- 
ment  lease of 61Cr* 
cytes 
A  C. parvurn 
B  BCG 
C  BCG 
Unseparated  5  x  105  24.0  63.8  +  1.2 
After FH:I:  5  x  106  4.6  65.8  +  4.0 
Unseparated  1 ×  106  12.2  86.8  +  1.5 
After FH  1 X  105  5.6  70.1  +  0.8 
Unseparated  4  ×  i05  9.5  63.4 +  2.0 
After FH  4  X  105  3.7  50.1  +  2.2 
Unseparated  2  X  105  9.5  39.3  +  1.5 
After FH  2  X  105  3.7  32.9  +  1.1 
* From 2  ×  10  4 SlCr-labeled P388 cells with PMA (10 ng/ml). Means :l: SEM for triplicates. 
:~ Cells taken from the upper layer after centrifugation on Ficoll-Hypaque (see Materials and Methods). 
the lysis caused by the same number  of each effector population  tested separately (not 
shown).  Thus  there  was  no  evidence  that  granulocytes  synergized  with  BCG  cells; 
they were simply additive. We  concluded  that both  granulocytes and  BCG-activated 
macrophages  were capable  of lysing P388 cells when  triggered with PMA. 
Lysis of Other Targets.  The  sensitivity to lysis of a  variety of targets was then tested, 
and compared  with their sensitivity to lysis by reagent H202.  As shown in Figs.  6  and 
7,  various ceils differed  in their susceptibility  to  lysis in both  tests.  For example,  the 
concentration  of H202  causing 50%  specific release of S1Cr ranged  from  3.63  ×  10  -6 
M  in  the  case  of  P388  to  3.85  ×  10  -5  M  for  J774.  The  correlation  between 
susceptibility  to  lysis  by  PMA-triggered  granulocytes  and  by  reagent  H202  was 
extremely close  (r  =  0.98)  (Fig. 8). 
In  less  extensive  tests,  BCG-induced  peritoneal  cells  demonstrated  similar  results 
with  many  of the same  target  cells.  For example,  PMA-triggered  BCG  cells caused 
86% specific release of 51Cr from syngeneic erythrocytes at  E:T  ratios as low as 0.047 NATHAN,  BRUKNER,  SILVERSTEIN,  AND  COHN  93 
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FIG. 6.  Susceptibility of various target ceils to lysis by PMA-triggered peritoneal granulocytes. 2 
X  104 SlCr-labeled target cells were cultured for 4.5 h with 10 ng/ml PMA plus varying numbers 
of peritoneal exudate cells collected 17 h after injection of thioglycollate broth (78.6% granuloeytes). 
The target cells and their spontaneous release of SlCr with PMA, followed by their specific release 
when  incubated  with a  40-fold excess of granulocytes but  without  PMA, were:  O  O,  P388 
(14.7%,  -1.6%);  0----0, TLX9  (12.4%,  -4.2%);  •  •,  L  cells (33.9%,  2.7%);  × ..... X, spleen 
cells (19.8%,  5.7%);  A  A, J774  (17.2%,  1.1%).  Means of triplicates.  SEM  ranged from  1.2  to 
3.0%. 
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FIG.  7.  Susceptibility of various target cells to lysis by reagent H202.  Cells cultured as in Fig. 6, 
but with reagent H202 instead of effector cells and PMA. Notation of cell types as in legend of Fig. 
6. Means of triplicates. SEM ranged from 1.5 to 3.6%. 
(1:21),  50% of maximum release at an E:T ratio of 0.025  (1:40), and significant lysis 
(10.8% :1: 0.5) at an E:T ratio of 0.016  (1:63). One-half-maximal lysis of erythrocytes 
by syngeneic granulocytes, in comparison, occurred at an E:T ratio of 0.017  (1:60). 
Use of Agents Other than PMA.  It was of interest  to test other soluble substances 
which, like  PMA, are membrane-active, but which would not trigger H202 release. 
LPS and digitonin have both been reported to stimulate hexose monophosphate shunt 
activity (19) and superoxide release (14, 20, 21) from leukocytes. Yet, we have been 94  I.  CYTOLYSIS  BY  MACROPHAGES  AND  GRANULOCYTES 
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Fro.  8.  Comparison of susceptibility to lysis by reagent HzOz and by PMA-triggered granulocytes 
for 10 types of SlCr-labeled target cells. From titrations like those shown in Figs. 6 and 7, the percent 
specific release of SlCr was determined for each target cell when incubated with 1 ×  10  -5 M  H~)2 
or with 1.5  X  l0  b granulocytes plus 10 ng/ml PMA. The results are plotted relative to the equivalent 
values for  P388 cells in the same experiment. All target  cells were tested at  2  ×  104, except for 
erythrocytes at 3  ×  106 per tube. The line (least squares fit) has a  slope of 0.98 and a  correlation 
coefficient of 0.98. 
TABLE  V 
Effect of Membrane-Active  Agents on Cytotoxicity 
Agent added*  Percent specific release:~ 
DMSO vehicle§  -3.3  ±  1.3 
LPSI]  3.0 ±  0.6 
Digitonin¶  3.9 ±  1.0 
PMA**  71.2  ±  3.8 
* Effector cells were BCG-induced peritoneal cells at E:T ratio of 18. 
:[: Means  +  SEM  for  triplicates  with  2  ×  104  51Cr-labeled  P388  cells. 
Spontaneous release for each set, in the order listed, was 12.2, 9.9, 9.9, and 
12.6%. 
§ DMSO, 0.0033% (vol/vol). 
[[ LPS, lipopolysaccharide from E. coli 027:B8, butanol extracted, 30 #g/ml. 
¶ Digitonin, 0.3 #g/ml. 
** PMA,  10 ng/ml. 
unable to detect H202  release from BCG-induced macrophages using five preparations 
of LPS (see Materials and Methods) over the range from 333 pg/ml to 33 #g/ml for 
up to 1.5 h after addition, nor from mouse peritoneal granulocytes using digitonin in 
the range from  10 ng/ml to  I0 ~g/ml, which was toxic. When added to cultures of 
BCG-induced peritoneal cells and P388 cells, neither LPS nor digitonin caused 5aCr 
release, although PMA did (Table V). 
Suitable  concentrations  of NaF  (20  mM)  (22)  and  A23187  (0.33  #g/ml)  (23) 
triggered H202 release, but were toxic to P388 cells at the same concentrations. 
Discussion 
These results establish a  close correlation between hydrogen peroxide release and 
the extracellular cytotoxicity of activated macrophages and granulocytes when phar- 
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The  present  findings  differ  from  most  reports  of immunologically  nonspecific 
macrophage-mediated cytotoxicity in  several  respects.  The cytotoxic effects in  the 
present model were extremely rapid, with nearly maximal release of ~lCr within 4.5 
h,  and  with  evidence that  injury  to  the  target  cells  was  complete within  1 h,  in 
contrast to systems in which injury was apparent between about 18 h and 5 d (24-30). 
The cytotoxicity was associated with target cell death, rather than reversible cytostasis 
(31).  The  cytotoxic activity  of effector cells  was  potent,  with  50%  lysis  of P388 
lymphoma cells occurring at E:T ratios of 1.4-4.5, and 50% lysis of mouse erythrocytes 
at E:T ratios of 0.017-0.025. 
Most likely, the rapidity and potency of  effects were due to pharmacologic triggering 
of the  macrophages and  granulocytes. We felt such a  system deserved study, both 
because it  facilitated analysis at  the biochemical level, and  because it might  be a 
model for other forms of macrophage-mediated cytotoxicity whose induction can be 
resolved into the same two steps, that is, activation and triggering. 
Russell,  Doe, and  Mclntosh  (32), and  Doe and  Henson  (33), demonstrated  51Cr 
release from P815 mastocytoma cells when the latter were cultured with macrophages 
from tumors (32) or thioglycollate-induced exudates (33) plus LPS. We considered an 
agent to trigger a response when the response was absent or very small until the agent 
was  added,  and  appeared  very  rapidly  thereafter.  The  requirement  for  16  h  of 
exposure  to  LPS  in  the  studies  cited  (33)  makes  it  likely  that  LPS  acted  as  an 
activating agent, rather than as a triggering agent. It is not clear whether LPS might 
thereafter have also acted as a  triggering agent, or in some other capacity, such as 
through activation of complement components released by the macrophages. Thus, 
our inability to trigger cytotoxicity with LPS may be due to fundamental differences 
in kinetics of the assays, or less likely, to differences in LPS preparations, effector cells, 
or target cells. The same points arise in comparing the present findings with those of 
Weinberg, Chapman  and Hibbs (34), concerning LPS enhancement of macrophage 
anti-tumor activity in a 60-h assay (34). 
We compared eight types of effector cells.  They varied from strongly cytotoxic to 
completely noncytotoxic. Their activity in the cytotoxicity assay correlated with their 
ability to release H202 in response to the same triggering agent, PMA.  Specifically, 
macrophages activated by treatment of the mice with BCG or C. parvum were highly 
effective, as were mouse peritoneal granulocytes. All three cell populations released 
abundant  H202  in  response  to  PMA  (13).  Casein-induced  peritoneal  cells  were 
intermediate in efficacy in both assays. Normal peritoneal macrophages, and macro- 
phages  elicited with  thioglycollate broth  or proteose-peptone, which  released very 
little H202 in response to PMA, were inactive. Also inactive was the macrophage-like 
tumor line, J774 (18), which released no detectable H202. 
On the other hand, there was a discrepancy between cytotoxic potency and previous 
reports of superoxide release from various preparations of macrophages. For example, 
PMA was  found to trigger as  much superoxide release  from thioglycoUate-elicited 
macrophages as from BCG-activated macrophages (14). J774 also released substantial 
amounts of  superoxide (14). Because extracellular superoxide anion would be expected 
to  dismutate  spontaneously  to  hydrogen  peroxide,  our  inability  to  detect  either 
cytotoxicity or substantial amounts of extraceUular hydrogen peroxide using thiogly- 
collate-elicited macrophages and J774 cells was unexpected. Possible explanations for 
this apparent paradox are under study. 
Granulocytes  were  roughly  twice  as  potent  as  BCG-activated  macrophages  in 96  I.  CYTOLYSIS  BY  MACROPHAGES  AND  GRANULOCYTES 
cytotoxicity  and  in  H202  release.  In  part,  this  may  be  due  to  inclusion  of some 
nonphagocytic  adherent  cells  in  the  tally of macrophages,  because  the  former are 
inactive in this system. Apart from nonphagocytic adherent cells (NPAC), there was 
extreme heterogeneity  in  size  and  cytologic maturity among the macrophages and 
monocytes  in  the  BCG-induced  population.  It  is  possible  that  a  subpopulation 
accounted  for much of the activity, and was correspondingly more potent on a  per 
cell basis. 
10 types of target cells were compared for susceptibility to lysis, both by pharma- 
cologically triggered macrophages and granulocytes, and by reagent H202.  Suscepti- 
bility to lysis, although highly variable, was the same in both tests for a given type of 
target cell. The target cells used were malignant or normal, syngeneic, allogeneic, or 
xenogeneic,  adherent  or  nonadherent,  lymphocytic,  erythrocytic,  fibroblastic,  or 
macrophage like,  murine  or human.  Too few cells  were tested  to  generalize about 
their susceptibility to lysis in terms of any of these categories. 
The LDs0 for various target cells ranged from 3.63  x  10  -6 M  to 3.85  ×  10  -5 M 
H202.  BCG-activated macrophages continued  to release HzOz at  a  nearly constant 
rate for at least  1 h after the addition of PMA. In a previous study, the mean rate of 
release of H202 after addition  of PMA was  7.9  nmol/106 cells per 5 min for BCG- 
induced macrophages, and 9.5 nmol for granulocytes (13).  For unknown reasons, the 
corresponding values during the present study were lower (2.5  and 5.8, respectively). 
Using the lower values, and assuming there are 4  X  105 macrophages in the typical 
assay to which  106 BCG-induced peritoneal cells are added in a  final volume of 2 ml, 
the H202 concentration would be expected to reach 6  X  10  -6 M  in the  Ist h, which 
corresponds to the period of injury. For granulocytes, 6.6  X  105 polymorphonuclear 
leukocytes  in  the  standard  assay  using  106  peritoneal  cells  would  be  expected  to 
generate  2.3  ×  10  -s  M  H202  in  the  same period.  Although  these calculations  are 
useful, caution is needed in their interpretation.  First, reagent H202 was added as a 
bolus,  although  the cells released  H2Oz  as a  flux.  Catabolism may have prevented 
cell-derived  H202  from  reaching  the  projected  final  concentrations.  On  the  other 
hand,  the  concentration  of H202  in  the  vicinity of the  target  cells  may have been 
higher than calculated, because of their proximity to the effector cells. 
Of the three membrane-active agents tested, only the one triggering H202 release 
from activated  macrophages and  granulocytes  led  to  cytotoxicity when  those  cells 
were cultured  with  tumor cells.  The dose-response curve for PMA was the same in 
both assays. 
The above findings point strongly to a role for hydrogen peroxide in the extracellular 
cytotoxic mechanisms of activated macrophages, and tend to confirm the findings of 
others using granulocytes (8, 9). However, the evidence presented here is circumstan- 
tial. Further experiments were designed to learn whether hydrogen peroxide release 
from activated macrophages was both necessary and sufficient  for cytotoxicity. The 
results are described in the accompanying report (15). 
Summary 
Lymphoma cells were rapidly lysed by activated macrophages and granulocytes in 
the presence of PMA.  Release of SaCr from lymphoma cells correlated closely with 
their destruction  as viewed by scanning electron microscopy, and with reduction  in 
the number of trypan blue-excluding cells. The standard  assay involved 5XCr release NATHAN, BRUKNER, SILVERSTEIN, AND COHN  97 
measured at 4.5 h, but injury appeared to be complete in 1 h. Of eight different types 
of effector cells tested, only those releasing abundant H202 in response to PMA were 
effective, that is, BCG-, C. parvum-, or casein-activated macrophages, or thioglycollate- 
elicited granulocytes. Normal macrophages, J774 cells, or macrophages elicited with 
thioglycollate broth or proteose-peptone were ineffective. BCG-activated macrophages 
and granulocytes caused 50% specific release of 5XCr from P388 lymphoma cells at E: 
T  ratios between  1.4 and 4.5, and from mouse erythrocytes at E:T ratios of 0.017  to 
0.025.  10 types of target cells varied widely in their susceptibility to lysis by reagent 
H~O2, with  one-half-maximal lysis occurring  at  H202  concentrations  ranging from 
3.63  ×  10  -6 M  to 3.85  ×  10  -5 M. Effector cells were expected to generate approxi- 
mately that much H202 during the period of injury. Susceptibility of the target cells 
to  lysis by  PMA-triggered  granulocytes  correlated  closely with  their  sensitivity  to 
H202  (r  =  0.98).  The membrane-active agents  LPS and  digitonin,  which  did  not 
trigger H202 release, did not trigger cytotoxicity. The dose-response curve for trigger- 
ing of H202 release by PMA was identical to that for triggering cytotoxicity. These 
results  provided  strong  circumstantial  evidence  for  the  importance  of  H202  in 
extracellular cytolysis by activated macrophages and granulocytes when pharmaco- 
logically triggered. 
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